DSM BioSolutions has entered into an agreement with Laboratoires Mayoly Spindler, of Chatou Cedex, France, for the manufacture of “MS1819” lipase. DSM has successfully completed process development and commenced cGMP manufacture of the Mayoly Spindler lipase compound for preclinical and Phase I trial supplies. DSM BioSolutions manufactures the lipase compound at its microbial fermentation facility located in Capua, Italy. Lipase is an enzyme for the treatment of Exocrine Pancreati...